Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells (original) (raw)

• Akiri G, Cherian MM, Vijayakumar S, Liu G, Bafico A, Aaronson SA . (2009). Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma. Oncogene 28: 2163–2172.
  Article CAS PubMed Central PubMed Google Scholar
• Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR . (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489–27494.
  Article CAS PubMed Google Scholar
• Bafico A, Gazit A, Wu-Morgan SS, Yaniv A, Aaronson SA . (1998). Characterization of Wnt-1 and Wnt-2-induced growth alterations and signaling pathways in NIH3T3 fibroblasts. Oncogene 16: 2819–2825.
  Article CAS PubMed Google Scholar
• Bas PLW, Friedel N, Nico JDB, Hugo WT, Winand NMD . (2000). Genetic alterations involving exon 3 of the β-catenin gene do not play a role in adenocarcinomas of the esophagus. Int J Cancer 86: 533–537.
  Article Google Scholar
• Bechard M, Dalton S . (2009). Subcellular localization of glycogen synthase kinase 3-β controls embryonic stem cell self-renewal. Mol Cell Biol 29: 2092–2104.
  Article CAS PubMed Central PubMed Google Scholar
• Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A et al. (1999). β- and γ-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ 10: 369–376.
  CAS PubMed Google Scholar
• Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C et al. (2002). β-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 62: 3503–3506.
  CAS PubMed Google Scholar
• D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE et al. (2001). c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 7: 235–239.
  Article CAS PubMed Google Scholar
• Filali M, Cheng N, Abbott D, Leontiev V, Engelhardt JF . (2002). Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter. J Biol Chem 277: 33398–33410.
  Article CAS PubMed Google Scholar
• Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV et al. (1993). Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34: 1394–1396.
  Article CAS PubMed Central PubMed Google Scholar
• Grabsch H, Takeno S, Noguchi T, Hommel G, Gabbert HE, Mueller W . (2001). Different patterns of β-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome. Histopathology 39: 141–149.
  Article CAS PubMed Google Scholar
• He T-C, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512.
  Article CAS PubMed Google Scholar
• Ikenoue T, Ijichi H, Kato N, Kanai F, Masaki T, Rengifo W et al. (2002). Analysis of the β-catenin/T-cell factor signaling pathway in 36 gastrointestinal and liver cancer cells. Jpn J Cancer Res 93: 1213–1220.
  Article CAS PubMed Central PubMed Google Scholar
• Jang JW, Boxer RB, Chodosh LA . (2006). Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis. Mol Cell Biol 26: 8109–8121.
  Article CAS PubMed Central PubMed Google Scholar
• Janssen K-P, Alberici P, Fsihi H, Gaspar C, Breukel C, Franken P et al. (2006). APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 131: 1096–1109.
  Article CAS PubMed Google Scholar
• Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F . (2002). Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172–1183.
  Article CAS PubMed Central PubMed Google Scholar
• Kim J-S, Crooks H, Dracheva T, Nishanian TG, Singh B, Jen J et al. (2002). Oncogenic β-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res 62: 2744–2748.
  CAS PubMed Google Scholar
• Kim S-E, Lee W-J, Choi K-Y . (2007). The PI3 kinase-Akt pathway mediates Wnt3a-induced proliferation. Cellular Signal 19: 511–518.
  Article CAS Google Scholar
• Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR et al. (2000). γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin. Genes Dev 14: 1319–1331.
  CAS PubMed PubMed Central Google Scholar
• Michl P, Downward J . (2005). Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers. Z Gastroenterol, 1133–1139.
  Article CAS PubMed Google Scholar
• Morin PJ, Spa rks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al. (1997). Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787–1790.
  Article CAS PubMed Google Scholar
• Overman MJ . (2009). Recent advances in the management of adenocarcinoma of the small intestine. Gastrointest Cancer Res 3: 90–96.
  PubMed PubMed Central Google Scholar
• Park K-S, Jeon SH, Kim S-E, Bahk Y-Y, Holmen SL, Williams BO et al. (2006). APC inhibits ERK pathway activation and cellular proliferation induced by RAS. J Cell Sci 119: 819–827.
  Article CAS PubMed Google Scholar
• Pfaffl MW . (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
  Article CAS PubMed Central PubMed Google Scholar
• Pumiglia KM, Decker SJ . (1997). Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94: 448–452.
  Article CAS PubMed PubMed Central Google Scholar
• Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA . (1989). Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86: 802–806.
  Article CAS PubMed PubMed Central Google Scholar
• Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P . (1997). Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275: 1790–1792.
  Article CAS PubMed Google Scholar
• Shimizu M, Fukunaga Y, Ikenouchi J, Nagafuchi A . (2008). Defining the roles of β-catenin and plakoglobin in LEF/T-cell factor-dependent transcription using β-catenin/plakoglobin-null F9 cells. Mol Cell Biol 28: 825–835.
  Article CAS PubMed Google Scholar
• Slinker BK . (1998). The statistics of synergism. J Mol Cell Cardiol 30: 723–731.
  Article CAS PubMed Google Scholar
• Stampfer MR, Bartley JC . (1985). Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci USA 82: 2394–2398.
  Article CAS PubMed PubMed Central Google Scholar
• Sunaga N, Kohno T, Kolligs FT, Fearon ER, Saito R, Yokota J . (2001). Constitutive activation of the Wnt signaling pathway by CTNNB1 (β-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer 30: 316–321.
  Article CAS PubMed Google Scholar
• Suriano G, Vrcelj N, Senz J, Ferreira P, Masoudi H, Cox K et al. (2005). β-Catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer. Genes Chromosomes Cancer 42: 238–246.
  Article CAS PubMed Google Scholar
• Teuliere J, Faraldo MM, Shtutman M, Birchmeier W, Huelsken J, Thiery JP et al. (2004). β-Catenin-dependent and -independent effects of δ N-plakoglobin on epidermal growth and differentiation. Mol Cell Biol 24: 8649–8661.
  Article CAS PubMed Central PubMed Google Scholar
• Tomita H, Yamada Y, Oyama T, Hata K, Hirose Y, Hara A et al. (2007). Development of gastric tumors in ApcMin/+ mice by the activation of the β-catenin/Tcf signaling pathway. Cancer Res 67: 4079–4087.
  Article CAS PubMed Google Scholar
• Van Cutsem E, Dicato M, Arber N, Benson A, Cunningham D, Diaz-Rubio E et al. (2006). The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005. Ann Oncol 17: vi13–vi18.
  Article PubMed Google Scholar
• van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A et al. (2002). The (β)-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241–250.
  Article CAS PubMed Google Scholar
• Vlahos CJ, Matter WF, Hui KY, Brown RF . (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241–5248.
  CAS PubMed Google Scholar
• Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH . (2001). Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines. Int J Cancer 95: 108–113.
  Article CAS PubMed Google Scholar
• Zhurinsky J, Shtutman M, Ben-Ze′ev A . (2000). Differential mechanisms of LEF/TCF family-dependent transcriptional activation by β-catenin and plakoglobin. Mol Cell Biol 20: 4238–4252.
  Article CAS PubMed Central PubMed Google Scholar